Ryan Lynch
Insider
First SEC filing: June 23, 2025 · Latest: June 23, 2025
Insider at
Insider transactions
0 buys (P)
2 sells (S)
Net: $-12,661
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 16, 2026 | CBIO | S 10b5-1 | 240 | $17.90 | $4,296 | 13,631 Direct | -1.73% | Disposed | -20.0% (price as of 2026-10-02) |
| June 22, 2026 | CBIO | S 10b5-1 | 465 | $17.99 | $8,365 | 13,871 Direct | -3.24% | Disposed | -20.4% (price as of 2026-10-02) |
| Dec. 15, 2025 | CBIO | A | 8,378 | · | · | 8,378 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 15, 2025 | CBIO | A | 4,000 | · | · | 12,378 Direct | +47.74% | Acquired | (price as of 2026-10-02) |
| Dec. 15, 2025 | CBIO | A | 33,512 | · | · | 33,512 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | CBIO | Stock Option (Right to Buy) | Ordinary Shares | $13.21 | Dec. 15, 2035 | 33,512 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 23, 2025 | CBIO | Stock Option (Right to Buy) | 105,706 | Direct |